Partnerships
Partnerships in European countries
In addition to countries where it has a direct presence, Cephalon has partnerships with well established local pharmaceutical companies in the major European markets which allow the company access to rapidly growing markets.
- Austria, Belgium, Bosnia Herzegovina, Bulgaria, Croatia, Cyprius, Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Iceland, Italy, Latvia, Lithuania, Luxemburg, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, The Netherlands and Turkey
Partnerships in African countries
Cephalon distributes its flagship product, SPASFON® (phloroglucinol), an antispasmodic indicated in various abdominal diseases in French speaking African countries and the Maghreb region.
- Algeria, Cameroon, Congo, Ivory Coast, Mali, Morocco, Senegal, Tunisia...
Expanding in the Middle East region
Cephalon has recently expanded its development in the Middle East region through partnerships in Persian Gulf countries.